Epigenetics Market Report of Trends, Demands & Industry Prospect 2017 Oct 2017

The Epigenetics Market is projected to register a CAGR of 13.5% during the forecast period
(2017–2022). The Epigenetics Market is growing and the experts have predicted the future stats
of Epigenetics. Epigenetics Market report contains the top corporate profiles and strategies
with industry analysis and trends.
Complete report is now available on Epigenetics Market by Product (Kit, Enzymes, Reagent,
NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology,
Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic,
CRO) - Global Forecast to 2022at http://www.rnrmarketresearch.com/epigenetics-
technology-market-epigenomics-dna-methylation-histone-modifications-rna-interference-
cancer-therapeutics-personalized-medicine-2012-2017-market-report.html
The global epigenetics market is projected to reach USD 1,605.7 million by 2022 from USD
854.0 million in 2017, at a CAGR of 13.5% during the forecast period. The decreasing
sequencing costs and time, increasing research activities, favorable funding scenario for
epigenetics research, rising prevalence of cancer are the key factors driving market growth
during the forecast period. On the other hand, the high cost of instruments is expected to
restrain the growth of this market to a certain extent.
On the basis of application, the epigenetics market is segmented into oncology, metabolic
diseases, developmental biology, immunology, cardiovascular diseases, and other applications
(includes neurology, gynecology, and infectious diseases). In 2016, the oncology segment
accounted for the major share of the global epigenetics market. The large share of this segment
is attributed to the rising prevalence of cancer and the increasing number of research-related
activities.
Get Discount on Epigenetics Market Report at
http://www.rnrmarketresearch.com/contacts/discount?rname=68045
Break of primary participants in Epigenetics Market was as mentioned below:
By company type: Tier 1 – 35%, Tier 2 – 45%, and Tier 3 – 20%
By designation: C-level – 35%, Director level – 25%, and Others – 40%
By region: North America – 48%, Europe – 22%, APAC – 22%, Latin America –4%, and MEA–4%
Major players of Epigenetics Market Report are:
The prominent players in the epigenetics market include Illumina (US), Thermo Fisher (US),
Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif
(US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), and Bio-
Rad (US).